Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating desvenlafaxine succinate sustained-release in outpatients with major depressive disorder completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Pristiq (Desvenlafaxine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2010-11-25